Covered recipient · General Payments record
MARK WEISSMAN
General Payments · PY2018–2022
$1,534.96
- Reported across 124 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $272.44 | 14 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $74.91 | 3 |
| SCYNEXIS, Inc. | $62.97 | 4 |
| PFIZER INC. | $37.46 | 2 |
| Gilead Sciences, Inc. | $24.86 | 1 |
| TherapeuticsMD, Inc. | $22.73 | 1 |
| Mylan Pharmaceuticals Inc. | $19.75 | 1 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $15.09 | 1 |
| CooperSurgical, Inc. | $14.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (14)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.14 | 02/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892629505 | CMS |
| ABBVIE INC. | $29.17 | 05/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892629507 | CMS |
| ABBVIE INC. | $28.60 | 06/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892629509 | CMS |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.09 | 03/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923768331 | CMS |
| CooperSurgical, Inc. | $14.67 | 08/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955471225 | CMS |
| Gilead Sciences, Inc. | $24.86 | 05/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929567293 | CMS |
| Mylan Pharmaceuticals Inc. | $19.75 | 03/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 963965741 | CMS |
| PFIZER INC. | $19.21 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949138659 | CMS |
| PFIZER INC. | $18.25 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949157641 | CMS |
| SCYNEXIS, Inc. | $15.71 | 01/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905572691 | CMS |
| SCYNEXIS, Inc. | $16.47 | 03/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905572693 | CMS |
| SCYNEXIS, Inc. | $14.32 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905572689 | CMS |
| SCYNEXIS, Inc. | $16.47 | 05/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905572695 | CMS |
| TherapeuticsMD, Inc. | $22.73 | 02/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 930768983 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.